TAK1 contributes to the enhanced responsiveness of LTB 4 -treated neutrophils to Toll-like receptor ligands

Author： Gaudreault Éric  

Publisher： Oxford University Press

ISSN： 1460-2377

Source： International Immunology, Vol.24, Iss.11, 2012-11, pp. : 693-704

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood

By De Wit D.   Tonon S.   Olislagers V.   Goriely S.   Boutriaux M.   Goldman M.   Willems F.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 277-281

Elsevier

Access to resources Recommend Favorite

Skin-induced tolerance and its reversal by Toll-like receptor ligands

By Szczepanik Marian  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 3, 2007-06 ,pp. : 161-172

Springer Publishing Company

Access to resources Recommend Favorite

Toll‐like receptor 4 plays a protective role in pulmonary tuberculosis in mice

By Branger Judith  

International Immunology, Vol. 16, Iss. 3, 2004-03 ,pp. : 509-516

Oxford University Press

Access to resources Recommend Favorite

The Role of Toll-Like Receptor Pathways in the Mechanism of Type 1 Diabetes

By  

Current Molecular Medicine, Vol. 9, Iss. 1, 2009-02 ,pp. : 52-68

Bentham Science Publishers

Access to resources Recommend Favorite

Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands

By Horner A.A.   Raz E.  

Current Opinion in Immunology, Vol. 15, Iss. 6, 2003-12 ,pp. : 614-619

Elsevier

Access to resources Recommend Favorite